Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06750419 |
| Consolidated Lead Sponsor | Telix Pharmaceuticals (Innovations) Pty Limited |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 82 participants (ESTIMATED) |
| Registered Start Date | 2024-11-06 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Beijing Cancer Hospital | Beijing, China | Open Hospital Dossier -> |
| Zhejiang Provincial People's Hospital | Hangzhou, China | Open Hospital Dossier -> |
| Zhongshan Hospital Fudan University | Shanghai, China | Open Hospital Dossier -> |
| The First Affiliated Hospital Of Soochow University | Suzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.